Consainsights logo
  • Reports /
  • Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market Market Research Report – Segmented By Product (Instruments, Kit and Reagents, Software and Services), By Application (Infectious Diseases, Genetics, Other Applications), By Technology (PCR, Microarray, DNA Sequencing) & Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.

Table of contents

Executive Summary

Veterinary Molecular Diagnostics Market was valued at US $7.38 billion in 2021 and is projected to grow at 11.28% CAGR over the forecast period to reach US $14.01 billion by 2027. Veterinary Molecular Diagnostics Market represented US $1.42 billion opportunity over 2019-2021 and estimated to create US $6.63 billion opportunity in 2027 over 2021.

Veterinary Molecular Diagnostics Market Size (2019 - 2027), USD billion

Veterinary Molecular Diagnostics from Consainsights analyses the Veterinary Molecular Diagnostics Market in the Life Sciences industry over the forecast period to 2027.

Veterinary Molecular Diagnostics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Veterinary Molecular Diagnostics segmentation includes Product, Application, Technology and Geography.

Based on the Product, the Veterinary Molecular Diagnostics analysis covers Instruments, Kit and Reagents, Software and Services.

In Product segment, Instruments segment has highest cagr growth of 9.97%.

Revenue Share (%), By Product (2021)

Based on the Application, the Veterinary Molecular Diagnostics analysis covers Infectious Diseases, Genetics, Other Applications.

In Application segment, Infectious Diseases segment has highest cagr growth of 9.97%.

Revenue Share (%), By Application (2021)

Based on the Technology, the Veterinary Molecular Diagnostics analysis covers PCR, Microarray, DNA Sequencing.

In Technology segment, PCR segment has highest cagr growth of 9.97%.

Revenue Share (%), By Technology (2021)

Based on the region, the Veterinary Molecular Diagnostics analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Biochek BV, Biomerieux SA, Bioneer Corporation, Idexx Laboratories Inc., Ingenetix GmbH, Neogen Corporation, Thermo Fischer Scientific Inc., Veterinary Molecular Diagnostics Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Instruments segment has the highest revenue of US $3.97 billion and is expected to grow at CAGR of 9.97% by 2027 Instruments segment has highest cagr growth of 9.97%.

Veterinary Molecular Diagnostics Market Y-o-Y Growth (USD billion), By Product 2019 - 2027
Veterinary Molecular Diagnostics Market Size, By Product, 2019-2027 (USD billion)

Instruments

Instruments segment was valued at US $3.20 billion in 2019 and is projected to grow at 9.97% CAGR over the forecast period to reach US $7.53 billion by 2027. Instruments segment represented US $0.76 billion opportunity over 2019-2021 and estimated to create US $3.57 billion opportunity in 2027 over 2021.

Instruments - Historical, Forecast Market Sizes (USD billion), 2019 - 2027

Kit and Reagents

Kit and Reagents segment was valued at US $1.37 billion in 2019 and is projected to grow at 9.97% CAGR over the forecast period to reach US $3.23 billion by 2027. Kit and Reagents segment represented US $0.33 billion opportunity over 2019-2021 and estimated to create US $1.53 billion opportunity in 2027 over 2021.

Kit and Reagents - Historical, Forecast Market Sizes (USD billion), 2019 - 2027

Software and Services

Software and Services segment was valued at US $1.38 billion in 2019 and is projected to grow at 9.97% CAGR over the forecast period to reach US $3.25 billion by 2027. Software and Services segment represented US $0.33 billion opportunity over 2019-2021 and estimated to create US $1.54 billion opportunity in 2027 over 2021.

Software and Services - Historical, Forecast Market Sizes (USD billion), 2019 - 2027

Application

Introduction

In 2021, Infectious Diseases segment has the highest revenue of US $3.19 billion and is expected to grow at CAGR of 9.97% by 2027 Infectious Diseases segment has highest cagr growth of 9.97%.

Veterinary Molecular Diagnostics Market Y-o-Y Growth (USD billion), By Application 2019 - 2027
Veterinary Molecular Diagnostics Market Size, By Application, 2019-2027 (USD billion)

Infectious Diseases

Infectious Diseases segment was valued at US $2.58 billion in 2019 and is projected to grow at 9.97% CAGR over the forecast period to reach US $6.06 billion by 2027. Infectious Diseases segment represented US $0.61 billion opportunity over 2019-2021 and estimated to create US $2.87 billion opportunity in 2027 over 2021.

Infectious Diseases - Historical, Forecast Market Sizes (USD billion), 2019 - 2027

Genetics

Genetics segment was valued at US $1.87 billion in 2019 and is projected to grow at 9.97% CAGR over the forecast period to reach US $4.40 billion by 2027. Genetics segment represented US $0.45 billion opportunity over 2019-2021 and estimated to create US $2.09 billion opportunity in 2027 over 2021.

Genetics - Historical, Forecast Market Sizes (USD billion), 2019 - 2027

Other Applications

Other Applications segment was valued at US $1.51 billion in 2019 and is projected to grow at 9.97% CAGR over the forecast period to reach US $3.55 billion by 2027. Other Applications segment represented US $0.36 billion opportunity over 2019-2021 and estimated to create US $1.68 billion opportunity in 2027 over 2021.

Other Applications - Historical, Forecast Market Sizes (USD billion), 2019 - 2027

Technology

Introduction

In 2021, PCR segment has the highest revenue of US $3.38 billion and is expected to grow at CAGR of 9.97% by 2027 PCR segment has highest cagr growth of 9.97%.

Veterinary Molecular Diagnostics Market Y-o-Y Growth (USD billion), By Technology 2019 - 2027
Veterinary Molecular Diagnostics Market Size, By Technology, 2019-2027 (USD billion)

PCR

PCR segment was valued at US $2.73 billion in 2019 and is projected to grow at 9.97% CAGR over the forecast period to reach US $6.42 billion by 2027. PCR segment represented US $0.65 billion opportunity over 2019-2021 and estimated to create US $3.04 billion opportunity in 2027 over 2021.

PCR - Historical, Forecast Market Sizes (USD billion), 2019 - 2027

Microarray

Microarray segment was valued at US $1.70 billion in 2019 and is projected to grow at 9.97% CAGR over the forecast period to reach US $3.99 billion by 2027. Microarray segment represented US $0.40 billion opportunity over 2019-2021 and estimated to create US $1.89 billion opportunity in 2027 over 2021.

Microarray - Historical, Forecast Market Sizes (USD billion), 2019 - 2027

DNA Sequencing

DNA Sequencing segment was valued at US $1.53 billion in 2019 and is projected to grow at 9.97% CAGR over the forecast period to reach US $3.60 billion by 2027. DNA Sequencing segment represented US $0.37 billion opportunity over 2019-2021 and estimated to create US $1.71 billion opportunity in 2027 over 2021.

DNA Sequencing - Historical, Forecast Market Sizes (USD billion), 2019 - 2027